Insulet (PODD) Stock Price, Quote, News & History

Comments

Insulet Corp (PODD) Stock Price, Quote, News & History

PODDNASDAQ

Trade with Public

$199.42

-4.09-2.01%

At close: Apr 8, 5:00 PM EST

$199.42

-4.09-2.01%

Pre-Market: 5:09 AM EST

OverviewNews Earnings Options Guidance Analyst Ratings Insider Trades Short Interest Government Trades Stock Report

Key Statistics

Open

-

Close

$199.42

Volume / Avg.

0 / 1.04M

Day Range

- - -

52 Wk Range

197.54 - 354.88

Market Cap

$14.04B

P/E Ratio

57.28

Dividend Yield

-

Exchange

NASDAQ

RSI

22

Short Interest

5.53%

Days to Cover

2.37

Recent Insulet Corp News

Diabetes Focused MiniMed Recovery Story Builds As Pipeline Improves

MiniMed shows improved pipeline and valuation upside as insulin pump adoption grows despite rising competition and past share losses.

Vandana Singh

Insulet Stock Hits 52-Week Low - Here's Why

Insulet shares fall after the company warns certain Omnipod 5 Pods may under-deliver insulin, linked to reports of serious health events.

Vandana Singh

Diabetes-Focused Insulet Forecasts Strong 2026 Growth, Stock Soars

Insulet's stock rises 9% after beating Q4 earnings and offering strong 2026 guidance.

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

569.30M

Investing Cash Flow (TTM)

-222.70M

Financing Cash Flow (TTM)

-595.30M

Free Cash Flow (TTM)

349.90M

Capital Expenditure (TTM)

-219.40M

Net Change in Cash (TTM)

-248.80M

Analyst Trends and Forecast

3

Dec 25

1

Jan

11

Feb

1

Mar

1

Apr

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.1

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$14.04B

PE Ratio (TTM)

57.28

PE Ratio (FWD)

31.65

PEG Ratio (TTM)

1.10

PS Ratio (TTM)

5.29

PB Ratio (TTM)

9.11

Earnings Yield % (TTM)

1.75%

Earnings Yield % (FWD)

3.16%

EV / EBITDA (TTM)

28.69

Price / EBITDA (TTM)

29.28

Price / Free Cash Flow (TTM)

40.95

Book Value / Share

$21.88

Company Debt

Total Debt

$949.20M

LT Debt

$930.80M

LT Debt Issuance (TTM)

$506.10M

LT Debt Repayment (TTM)

-$1.21B

Total Cash

$716.10M

Debt to Equity

0.63

Issuance of Debt (TTM)

-$708.10M

Repayment of Debt (TTM)

-$1.21B

Key Statistics

Open

-

Close

$199.42

Volume / Avg.

0 / 1.04M

Day Range

- - -

52 Wk Range

197.54 - 354.88

Market Cap

$14.04B

P/E Ratio

57.28

Dividend Yield

-

Exchange

NASDAQ

RSI

22

Short Interest

5.53%

Days to Cover

2.37

About

Sector

Health Care

Industry

Health Care Equipment & Supplies

Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device that can be operated thro...

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS better than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS better than industry

FAQ

Q

How do I buy Insulet (PODD) stock?

A

You can purchase shares of Insulet (NASDAQ:PODD) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Insulet (PODD) competitors?

A

Other companies in Insulet’s space includes: Steris PLC (NYSE:STE), Masimo Corp (NASDAQ:MASI), Envista Holdings Corp (NYSE:NVST), Koninklijke Philips NV (NYSE:PHG) and Smith & Nephew PLC (NYSE:SNN).

Q

What is the forecast, or price target, for Insulet (PODD) stock?

A

Insulet has a consensus price target of $336.00.

Q

What is the current price for Insulet (PODD)?

A

The stock price for Insulet (NASDAQ: PODD) is $199.42 last updated April 9, 2026 at 4:05 PM EDT.

Q

Does Insulet (PODD) pay a dividend?

A

There are no upcoming dividends for Insulet.

Q

When is Insulet (NASDAQ:PODD) reporting earnings?

A

Insulet does not have any upcoming earnings scheduled.

Q

Is Insulet (PODD) going to split?

A

There is no upcoming split for Insulet.

Q

What sector and industry does Insulet (PODD) operate in?

A

Insulet is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NASDAQ.

People Also Watch

Envista Holdings Corp

NYSE:NVST

$26.67

%

Koninklijke Philips NV

Becton Dickinson & Co

NYSE:BDX

$155.46

%

Key Statistics

Open

-

Close

$199.42

Volume / Avg.

0 / 1.04M

Day Range

- - -

52 Wk Range

197.54 - 354.88

Market Cap

$14.04B

P/E Ratio

57.28

Dividend Yield

-

Exchange

NASDAQ

RSI

22

Short Interest

5.53%

Days to Cover

2.37

Recent Insulet Corp News

Diabetes Focused MiniMed Recovery Story Builds As Pipeline Improves

MiniMed shows improved pipeline and valuation upside as insulin pump adoption grows despite rising competition and past share losses.

Vandana Singh

Insulet Stock Hits 52-Week Low - Here's Why

Insulet shares fall after the company warns certain Omnipod 5 Pods may under-deliver insulin, linked to reports of serious health events.

Vandana Singh

Diabetes-Focused Insulet Forecasts Strong 2026 Growth, Stock Soars

Insulet's stock rises 9% after beating Q4 earnings and offering strong 2026 guidance.

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

569.30M

Investing Cash Flow (TTM)

-222.70M

Financing Cash Flow (TTM)

-595.30M

Free Cash Flow (TTM)

349.90M

Capital Expenditure (TTM)

-219.40M

Net Change in Cash (TTM)

-248.80M

Analyst Trends and Forecast

3

Dec 25

1

Jan

11

Feb

1

Mar

1

Apr

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.1

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$14.04B

PE Ratio (TTM)

57.28

PE Ratio (FWD)

31.65

PEG Ratio (TTM)

1.10

PS Ratio (TTM)

5.29

PB Ratio (TTM)

9.11

Earnings Yield % (TTM)

1.75%

Earnings Yield % (FWD)

3.16%

EV / EBITDA (TTM)

28.69

Price / EBITDA (TTM)

29.28

Price / Free Cash Flow (TTM)

40.95

Book Value / Share

$21.88

Company Debt

Total Debt

$949.20M

LT Debt

$930.80M

LT Debt Issuance (TTM)

$506.10M

LT Debt Repayment (TTM)

-$1.21B

Total Cash

$716.10M

Debt to Equity

0.63

Issuance of Debt (TTM)

-$708.10M

Repayment of Debt (TTM)

-$1.21B

Key Statistics

Open

-

Close

$199.42

Volume / Avg.

0 / 1.04M

Day Range

- - -

52 Wk Range

197.54 - 354.88

Market Cap

$14.04B

P/E Ratio

57.28

Dividend Yield

-

Exchange

NASDAQ

RSI

22

Short Interest

5.53%

Days to Cover

2.37

About

Sector

Health Care

Industry

Health Care Equipment & Supplies

Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device that can be operated thro...

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS better than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS better than industry